This Month In Muscular Dystrophy

Dr. Paul Martin Discusses Galgt2 Gene Therapy for Muscular Dystrophy Guest: Paul T. Martin, principal investigator, Center for Gene Therapy and Neurosciences Center, The Research Institute at Nationwide Children’s Hospital. Access an abstract of this month’s featured research article: AOverexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice. American Journal of Physiology - Cell Physiology. 2009 Mar, 296(3):C476-88. Epub 2008 Dec 24.